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The rabbit papilloma virus (Shope) gives rise under natural conditions to 
horny cutaneous growths in wild cottontails (1), and to papillomas of similar 
sort when inoculated into domestic rabbits.  The growths of both species may 
become malignant after a while through alterations in the virus-infected cells (2); 
but the virus has never been recovered from the cancers, nor can it be got ordi- 
narily from many of the papillomas induced with it in domestic rabbits.  Yet it 
persists in masked or altered form in the cancers as well as in the papillomas, as 
serological tests have proved: an antibody directed specifically against the virus 
appears in the blood of rabbits carrying the growths, and its titer rises as the 
tumors enlarge (3). 
One of the cancers originating in a virus-induced papilloma and transplanted 
successfully--the  V2  carcinoma--has  now  been  carried  through  21  tumor 
generations in  the  course of more than three years.  It grows  rapidly in  a 
considerable  proportion  of hosts  and  often metastasizes.  Tests  have  been 
made for the specific antiviral antibody in the blood of rabbits of every tumor 
generation,--more than a hundred animals in all.  This has never been found 
in  the blood of normal  control animals,  nor in  noteworthy titer  in  rabbits 
implanted with the tumor but negative; but it has regularly appeared in the 
blood of rabbits in which the V2 carcinoma has grown progressively, attaining a 
titer as high as that in animals which have long carried large papillomas, or 
even higher.  The strength of the antibody has been as great in recent tumor 
generations as in the early ones (3). 
The persistence of virus in the transplanted V2 carcinoma does not seem  re- 
mark,able when the fact is recalled that wholly extraneous, parasitic viruses-- 
vaccinia, virus III, yellow fever, infectious ectromelia, to name but a  few--can 
ride along as passengers in other transplanted tumors (4), as can also spiro- 
chetes, pleuropneumonia-like microorganisms, and various other bacteria (5). 
* Read in brief at the meetings of the American Association for Cancer Research, 
Chicago, April 15, 1941; abstract in Cancer Research, 1941, 1, 730. 
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But the fact is now becoming manifest that passenger viruses may disappear 
spontaneously from the tumors they ride upon, while some have been got rid of 
by transplanting the growth to hosts immune to the virus.  Rivers and Pearce 
observed long ago that virus III could vanish from the Brown-Pearce tumor as 
casually as it had appeared, and Andrewes recently noted that a rabbit sarcoma 
--the RSI--became free of passenger virus III when transplanted  through a 
rabbit previously immunized against it  (6).  He also found that the Brown- 
Pearce carcinoma could be rid of virus III by propagation in two successive 
virus III-immune rabbits, and from vaccine virus by passage through a single 
animal immune to it.  Identical results were got with the same materials by 
Pearce  (7). 
These findings bring up the possibility that the V2 carcinoma can be freed of 
associated virus by growing it in a succession of hosts immunized against this. 
The work here reported was done to learn whether such is the case.  The gen- 
eral plan was to propagate the V2 carcinoma in five successive groups of animals 
all hyperimmunized beforehand against the papilloma virus, and then to de- 
termine whether, upon return to normal hosts, the growth would elicit antiviral 
antibodies in the same high titer as before. 
Methods 
To hyperimmunize the rabbits to which the tumor was to be transferred,  four "pan- 
cake" papillomas  were produced  on the flanks of the animals  by rubbing a  potent 
virus suspension into areas of skin about 6 ×  8 cm. which had been freshly  scarified 
with  sandpaper.  Confluent  papillomatosis  usually  resulted  after  an  incubation 
period of about 10 days, and the growths rapidly  enlarged into characteristic  horny 
masses~ these often rising 2 cm. or more above the skin level.  Growths of this sort 
usually elicit antiviral antibody in considerable titer, and this can be greatly increased 
by repeated  injections of large quantities  of virus intraperitoneally,  as previous work 
has shown (8).  Accordingly, 10 days to 3 weeks after the scarifications, 10 cc. of a 
1:20 Berkefeld V filtrate of wild rabbit papillomas which were known to contain virus 
in  quantity  was injected  intraperitoneally  into each  animal.  The intraperitoneal 
injections were repeated  7 days later, and after a further interval  of 7 to 10 days the 
rabbits  were bled  from an  ear vein  and  the  sera  tested.  At this  time  they were 
implanted with the tumor. 
Much use was made of the complement fixation test to titer the antiviral  antibody. 
Previous work had demonstrated  its specificity and reliability as a gauge of immunity 
to the papilloma  virus  (9).  The test  was carried  out as  previously  described  (9), 
using 2 units of complement  (titrated immediately  beforehand) and 2 hours at room 
temperature  for fixation.  Antigen  from two  sources was used--the natural papil- 
lomas of W. R.  (wild cottontail rabbit)  1-28, and the pooled natural papillomas  of 
five cottontails,  P.  Both materials  yielded much virus.  A 1:120 saline extract of 
the glycerolated papillomas from both sources had been found in previous experiments 
to provide  an optimal quantity of antigen  (virus),  and hence this dilution  was uni- 
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fixation reaction provides a  comparative, not an  absolute, measure of the titer of 
antiviral antibody.  Sometimes the results with a single serum varied by as much as a 
twofold dilution in different tests; but the variation was never greater.  A serum can 
be considered very potent if, after dilution to 1:24 or more, it contains enough anti- 
body to fix completely 2  units of complement in mixture with an optimal dose of 
antigen.  Such a serum is capable of neutralizing many thousand infectious doses of 
virus, and an animal yielding it is usually resistant to infection with the virus, as 
previous studies have shown  (8).  In the present work the antibody titer has been 
expressed in  terms of the highest dilution of serum  that gave complete or almost 
complete fixation in the standard test.  Dilutions beyond 1:128 were not tested, for 
when  fixation is  complete at  this  dilution the  quantity  of antibody is great,  and 
hyperimmunization may be deemed maximal. 
The neutralization test for antiviml antibody was  also used.  It was applied as 
previously described  (14, 9). 
The virus suspensions for primary inoculation and subsequent hyperimmunization 
were made by grinding the glycerolated natural papillomas of cottontails in a mortar 
with sand and suspending the ground paste in physiological saline, usually 1:10 to 
1:20 (10 per cent and 5 per cent extracts).  The suspension was then spun clear, and 
sometimes passed through a Berkefeld V filter in addition.  To spread the conditions, 
five different virus materials were used, all highly pathogenic.  Always a  different 
material was  injected intraperitoneally from  that  with which  the  rabbit had  been 
cutaneously  inoculated. 
Normal adult gray brown rabbits (agouti hybrids) were used throughout, males and 
females indiscriminately.  All weighed 2.5 kilos or more. 
Transplantation of the tumor was effected by a  method somewhat different from 
that used in the previous work, in order to provide conditions under which the anti- 
viral antibody might have better opportunity to act.  A fine suspension of carcinoma 
tissue was used instead of hashed pieces, and the tissue was kept moist and finally 
suspended in  Tyrode to  which immune  serum had been added.  The  tumors were 
procured with aseptic precautions, and  the  "healthiest" portions carefully selected 
from nodules taken from at least two different situations in each animal.  By means 
of a small pestle, the tumor tissue was pressed through a 40-mesh monel metal sieve, 
with the addition of Tyrode-immune serum (usually 10 parts of Tyrode to one of the 
animal's own serum), the result being a  turbid, finely particulate suspension.  1 cc. 
portions of the suspension were then implanted into the leg muscles of the new hosts 
at six situations,--both forelegs and the anterior and posterior muscles of both thighs. 
The  fastest growing tumors were sometimes selected for transplantation and again 
slower-growing ones were utilized to  spread the  conditions. 
Successive  Transplantations  of  the  V2  Carcinoma  in  Virus-Immune  Rabbits 
The course of the transplantations is summarized in Chart 1. 
The Starting  Tumor.--The history of the V2 carcinoma has already been given in 
detail from its inception to the 13th serial transplantation, when the present experi- 
ments were begun  (3).  To procure material for them a  12th generation tumor was 
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the usual situations--in D.  R.  (domestic rabbit) 12-37, amongst others.  Palpable 
nodules were present in three of the situations when the animal was examined on the 
17th day, and in two more later on.  By the 42nd day the five nodules range from 1.2 
to 3.2 cm. in size.  All enlarged greatly in the ensuing 8 weeks, at length reaching 
diameters of 7.5  to 10.0 cm., the animal during this time becoming thin and weak. 
The antiviral antibody titer of its blood as determined by complement fixation was 
found to be 1 : 128 on the 107th day, when it was killed and the tumors procured for 
transplantation.  They were huge cysts of the sort already described (3), filled with 
thick, glairy, mucoid fluid in which floated yellowish gouts of necrotic material, and 
with walls 1 to 3 ram. thick, composed of pale-pink, close-texture tumor tissue.  The 
healthiest portions of the neoplastic tissue were pressed through the monel metal sieve 
and suspended in a mixture of Tyrode and the animal's own serum (proportion 20:1) 
First  Transfer  to  Hyperimmunized Rabbits, 14th Generation.--The  tumor suspen- 
sion of D. R. 12-37, described above, was implanted into the six muscle situations of 
six hyperimmunized rabbits.  At the time all bore four large confluent papillomatous 
masses, each about 6  X  8 cm. across and raised 0.4 to 0.8 cm., as result of inoculation 
30 days before with W. R. (wild rabbit) 1-72 virus, 1:20.  Intraperitoneal injections 
of 10 cc. of virus filtrate W. R. 1-68, 1:20, had been made on the 14th and 21st days 
and the serum antibody titers now ranged from 1:32 to 1:128.  Progressively enlarg- 
ing carcinomas developed in  three of the implanted animals, early regression took 
place in one, and no palpable tumors developed in the other two (see chart). 
Further  Transfers  in Hyperimmunized AnimaIs.--By the 40th day after implanta- 
tion the six growths of D. R.  1-77  (14th generation--hyperimmunized) had become 
cysts of characteristic sort, varying from 3.5 to 7.5 cm. in diameter.  The rabbit was 
bled and the complement fixation titer found to be 1:48.  It was killed and a  sus- 
pension made  by sieving the  healthy portions of its tumors  into  Tyrode plus the 
animal's own serum (10:1).  The suspension was then implanted into the leg muscles 
of twelve hyperimmunized rabbits (15th generation) all of which carried large con- 
fluent papillomas resulting from the inoculation of W. R.  1-28 virus, 1:10, 24 days 
before.  The animals had been injected intraperitoneaUy with 10 cc. of virus filtrate 
W. R. 16-96, 1 : 10, on the 12th day, and with 10 cc. of virus filtrate W.R. 1-68, 1 : 10, 
on the 18th day, and they now had serum antibody titers ranging from 1:48 to 1 : 128. 
The implantations resulted in progressively enlarging tumors in four rabbits, regres- 
sing ones in five, and no palpable growths in three. 
The details of the remaining transfers into hyperimmunized animals need not be 
given, for they do not differ significantly from those just furnished. 
The Eventual  Transfer  to Normal Animals.--Tumors  grew progressively in seven 
of  the  eight  implanted rabbits of  the  18th  generation--the fifth hyperimmunized 
group.  The growths of three  (D.  R.  14-21,  14-22,  and  14-23)  were implanted in 
normal rabbits, as indicated in the chart, each material into a different group of eight 
animals.  For the final transfers sieved suspensions were made as usual, but plain 
Tyrode was used instead of Tyrode plus host serum, since it was deemed advisable to 
avoid the passive transfer of antibody as possibly affecting the outcome of tests of the 
blood of the new hosts.  As the chart shows, the implantations from D.  R.  14-21 
grew progressively in half of the eight normal rabbits, regressing in the others; the 
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ones in four, and no palpable nodules in two; while the D. R. 14-23 material provided 
progressively enlarging tumors in five rabbits, regressing  growths in two, the eighth 
individual remaining negative.  Details of the serum tests will be given further on. 
General Findings 
When  viewed in  the large,  the results  of the  transfers,  as summarized in 
Chart 1, leave no doubt that the V2 carcinoma can be readily propagated in 
animals hyperimmunized against the papilloma virus.  It was maintained in 
this way in five successive tumor generations during nearly 8 months in all. 
Implantation of the growth into animals having very high titers of antiviral 
antibody often resulted in tumors that appeared promptly and grew progres- 
sively, frequently killing the hosts; but the outcome of the implantations varied 
much from one generation to the next and from individual to individual in the 
same generation.  The question arises, therefore, whether the tumor grew as 
well in virus-immune animals as in comparable normal ones.  Chart 1 goes far 
towards answering the question.  The cancer flourished in many of the hyper- 
immunized  hosts,  its  course  comparing  favorably with  that  in  the  tumor 
generations before hyperimmunization was undertaken  (3),  and when it was 
eventually returned to normal animals the number of "takes" and of progres- 
sively enlarging and regressing growths,  though differing somewhat from one 
group of hosts to another, was on the whole no different from that obtaining in 
the last generation of hyperimmunized rabbits.  To safeguard the tumor it had 
been propagated in  normal animals  as well as in  the  hyperimmunized ones 
throughout  the  period  of experimentation.  Hence  the  material  for  an  ad- 
ditional comparison is available (Table I). 
The passages in normal rabbits were made during the same months as those through 
the  hyperimmunized but  were  not  done  simultaneously,  and  the  materials  used, 
though of the  same tumor generations,  came of necessity from different groups of 
animals.  Furthermore, hashed tissue  was  implanted  into  the  new  normal hosts, 
and sieved suspensions into the hyperimmunized; and the animals of both groups were 
market bought, which is to say that none was pure bred.  Even so, it becomes evident 
from Table I that the outcome of implantations of the V2 carcinoma, though varying 
somewhat as in the case of other propagated neoplasms, was not significantly  different 
in the hyperimmunized and the normal rabbits.  "Takes" developed in two-thirds or 
more of the implanted rabbits in all of the groups (Table I).  Progressively enlarging 
tumors developed in from 28 to 87 per cent of the hyperimmunized animals and in 
from 17 to 54 per cent of the normals; while regression took place in from 13 to 56 per 
cent of the hyperimmunized rabbits and in from 33 to 83 per cent of the controls. 
From  the  findings  just  given  it  is  manifest  that  the  V2  carcinoma grew 
as well in the hyperimmunized rabbits as in the normals; and this fact makes it 
seem altogether unlikely that the antibody titer of the hyperimmune rabbits at 
the time of implantation would have any influence on the outcome.  That it 
had none can readily be seen from an inspection of Chart 1.  In the 14th gen- JOHN  o. XmD  13 
eration ,  for example,  tumors  enlarged progressively in  three  animals  having 
antibody titers when implanted of 1: 64, 1: 64, and  1: 32,  respectively;  no pal- 
pable nodules appeared in a rabbit with antibody titer of 1: 64; and regression of 
the growths took place in two  animals with  titers of  1:32 and 1:128, respec- 
tively.  So too in the 15th and the succeeding generations:  the tumors grew, or 
failed to develop, or regressed irrespective of the antibody titer at time of im- 
plantation. 
TABLE I 
Outcome of Implantations of the Vg Carcinoma in RabMts Hyperimmunized against the Papilloma 
Virus and in Normals 
Generation 
14th 
15th 
16th 
17th 
18th 
Number of rabbits 
implanted 
q;  tim-  Normal  H~ u  zed 
Number developing 
palpable nodules 
Hyperlm-  Normal 
munized 
4  8 
(67°/0)  (78%) 
9  8 
(75%)  (89%) 
6  11 
(84%)  (9S%) 
8  12 
(100%)  (100%) 
8  8 
(100%)  (100%) 
Number in  which 
tumors  grew  progres- 
sively 
Hyperim-  Normal 
muuized 
3  -;- 
(00%)  (r~%) 
4  3 
(33%)  (83%) 
2  2 
(~8%)  (17%) 
5  2 
(6~%)  (17%) 
7  4 
(87%)  (50%) 
Number in which 
tumors regressed 
Iyperim-  Normal 
munized 
1  3 
(17%)  (88%) 
5  5 
(49%)  (~%) 
4  9 
(66%)  (75%) 
3  10 
(~%)  (88%) 
1  4 
(18%)  (00%) 
Hybrid agouti rabbits  procured from various dealers were used throughout. 
The  transplantations  in  corresponding  hyperimmunized  and  normal  generations  were 
made during the same months but not simultaneously. 
No distinction is made in the table  between the animals in which regression was complete 
and the occasional ones in which it was partial and transitory,  i.e., individuals in which all of 
the tumors dwindled for a time and some disappeared but one or more later  enlarged. 
Attention may be called in passing to the fact that the antibody titers of the hyper- 
immunized rabbits  that provided tumors for transplantation  were lower when  the 
animals were killed than at time of the implantations, 40 to 52 days before (Chart 1). 
The finding was not unexpected.  For the high fiters resulting from the injections of 
large quantities of virus intraperitoneally are not maintained, as previous experience 
had shown, and the antibody response was presumably at or near its height at the time 
the  implantations  were made.  In many unimplanted  rabbits  immunized in  other 
experiments the antibody titers fell during the 6 to 8 weeks following the intraperi- 
toneal injections to less than one-half the maximum.  Manifestly the virus present in 
the large papillomas growing on the bellies  of the rabbits of the present experiments 
and in the V2 carcinomas proliferating in their leg muscles failed to keep the antibody 14  PARTNERSHIP  OF  NEOPLASTIC  VIRUS  AND  CARCINOMA  CELLS 
titer at its highest level.  Such findings will not seem strange to students of the infec- 
tious diseases.  Two possible reasons for them may be mentioned in the present case. 
The papillomas of domestic rabbits provide in general comparatively little antigenic 
stimulus, eliciting  much lower titers of antiviral antibody than do growths of com- 
parable size and duration in cottontails (9) ; and the V2 carcinoma, which eventually 
elicits very high titers of the antiviral antibody, does so only after the tumors have 
become large and cystic and have persisted for many weeks, as observations made 
recently with the collaboration of Dr. William F. Friedewald attest. 
It is of interest to compare the course of the implanted V2 carcinomas with 
that of the cutaneous papillomas present on the same animal, for the reason that 
their relation to the host is very different.  The cells of the V2 carcinoma come 
from another animal--the one in which this tumor first arose--whereas those of 
the papilloma are the animal's own, now infected with virus.  Regression of 
the V2 carcinoma, like that of other transplanted cancers, would appear to be 
consequent upon an induced  general resistance,  directed  against the foreign 
cells (10); whereas regression of the papilloma involves a  resistance which is 
directed  against such  of the  animal's own cells as have been rendered  neo- 
plastic by the virus (11).  In neither case does the antiviral antibody have any 
influence on the fate of the tumor: growths of both sorts often dwindle away in 
rabbits having little or no antiviral antibody in their blood, and they frequently 
grow progressively in other animals having high serum antibody titers.  Can 
it be that regression of the V2  carcinoma and that of the papilloma depend 
upon the same mechanism? 
A summary is given in Table II of the course of the papillomas and carcinomas in 
the 41 hyperimmunized rabbits of Chart 1.  The papillomas grew progressively in all 
of the rabbits except two, whereas in six rabbits no carcinomas appeared and in four- 
teen others they regressed  after having attained a diameter of 1 cm. or more by the 
16th day after implantation.  In twelve of them the nodules had regressed completely 
by the 40th day or shortly thereafter; in  the other two regression  was partial and 
transitory, with dwindling  of the nodules  between the 16th and 30th days, complete 
disappearance of several of them, and later enlargement of one or two. 
The V2 carcinoma grew progressively in  the one rabbit in which the papillomas 
regressed  entirely.  This animal  (D.  R.  12-83,  15th  generation--hyperimmunized) 
developed only scattered discrete  papillomas as result of the inunction of the highly 
pathogenic W. R. 1-28 virus, 1 : 10, and these attained a height of 1 to 2 ram. on the 
25th day; but had all regressed completely by the 38th day.  The V2 carcinomas, im- 
planted on the 25th day after virus inunction,  grew vigorously and progressively from 
the start at every situation, becoming 1.5 to 2.4 cm. in diameter by the 38th day, that 
is to say, during the period when the surface papillomas were regressing.  They con- 
tinued to enlarge,  formed huge cysts 4.0 to 6.0 cm. across,  and brought about the 
animal's death on the 88th day (63rd day after the implantations). 
From the data just given (Table II) it becomes evident that virus-induced 
papillomas of autochthonous origin  and V2 carcinomas resulting from trans- 
plantation may grow or regress independently of one another in the same host. ~0HN  G.  KIDD  15 
The findings do not allow a definite conclusion as to whether regression of the 
two types of growths is brought about by similar mechanisms, but they provide 
a  sound basis for doubting that the mechanism is identical in  the two cases. 
Local conditions and other factors as well have an important influence upon the 
course of virus-induced papillomas (11), and similar influences may be respon- 
sible for the highly various outcome of implantations with the V2 carcinoma. 
The passage of the V2 carcinoma through the hyperimmunized animals did 
not result in any perceivable alteration in the neoplasm.  Autopsies were done 
as routine on all animals dying from the tumor, and representative blocks were 
taken for microscopic study.  No differences could be made out between the 
growths in the hyperimmunized rabbits and those in the normals. 
TABLE II 
Fate of Autochtkonous  Virus-Induced  Patgllomas  and  Transplanted  V2  Carcinomas in tie 
Hyperimmunized Rabbits of Ckart 1 
Papillomas and carcinomas grew progressively  ............................. 
Papillomas grew progressively--carcinomas  failed to "take" ................. 
Papillomas grew progressivdy---carcinomas  regressed  ....................... 
Papillomas dwindled (partial regression) and carcinomas regressed completely. 
Papillomas regressed completely and carcinomas grew progressively  .......... 
Total ............................................................ 
Number of 
rabbits 
20 
6 
13" 
1 
1 
41 
* Partial regression in two. 
Tests for  Presence  of  Virus 
To determine whether the virus had persisted in the V2 carcinoma during its 
transfer serially through hyperimmunized animals, the growths of three rabbits 
of  the  18th  generation  (hyperimmunized)  were  transplanted  into  as  many 
groups of normals (Chart 1).  Later on tests were made for the antiviral anti- 
body in the blood of the rabbits in which the tumors had grown progressively. 
Table  III summarizes  the results  of the serum tests.  It will be seen that five of 
the rabbits  with carcinomas derived from D. R. 14-23 all had huge growths when bled 
on the 61st day following implantation.  Their sera contained  much antiviral anti- 
body, as manifested both by their capacity to react with the virus in the complement 
fixation test and by their ability to neutralize a potent suspension of it. t  The tumors 
grew progressively in only two of the rabbits implanted with the growths of D. R.  14-22 
and in only four of those implanted with the growths of D. R. 14-21.  The antiviral 
antibody was present in quantity in the sera of all these, as the table  shows. The sera 
The fact is  conspicuous  that the sera failed  to neutralize  the virus completely, 
though many had  high  titers  of antiviral  antibody as  determined  by complement 
fixation.  The phenomenon  has already been discussed in relation  to the limitations 
of the neutrafization  test as a gauge of antibody titer (12). @.~ 
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of the three normal controls exhibited no capacity to fix complement and were devoid 
of ability  to neutralize  the virus. 
Special  attention  should be  called  to  the findings  with  the  sera  of D.  R.  15-44 
and 15-55, rabbits implanted respectively with the growths of D. R. 14-22 and 14-21. 
In D. R. 15-44, nodules 1.0 to 2.5 cm. in diameter had appeared at all six situations 
by the 17th day following implantation.  They measured from 1.8 to 4.0 cm. on the 
29th day, but during the ensuing 2 weeks all abruptly vanished except  the largest, 
which dwindled to a softish nodule 1.2 cm. across.  Later on this gradually enlarged 
and it had become a  thin-walled cyst 3.5  cm. across at the time of bleeding.  The 
serum of this rabbit had no detectable capacity to fix complement, but it possessed the 
power to neutralize partially a  1 per cent virus filtrate (Table III).  The growths of 
D. R. 15-55 were indolent.  Palpable nodules 0.4 and 1.2 cm. across were present in 
only two of the six implanted situations on the 15th day.  Five nodules measuring 
0.4 to 2.0 cm. had appeared by the 27th day, but these dwindled during the next 
2 weeks and all had disappeared  when the animal was bled on the 55th day.  The 
animal's serum had only the slightest complement-fixing capacity, though it neutral- 
ized  a  considerable  proportion of the  test  virus  as  the  table  shows.  The  results 
contrast sharply with those got with  the sera of rabbits  in which the  tumors had 
grown big.  They conform to a  general rule, namely, that rabbits in which the V2 
carcinoma fails to grow, and those in which it regresses  before it has got large, fail 
as a rule to develop the antiviral antibody in quantity (3). 
The telltale  antibody in the blood of all of the rabbits  in which the cancer 
grew (Table III) makes plain the fact that the virus was still associated with 
the  V2  carcinoma  despite  the  propagation  of the  tumor  during  a  period  of 
nearly  8  months  in  hosts  hyperimmunized  against  it.  The  fact  that  the 
antibody appeared in as high titer as previously when the growth was returned 
to normal animals indicates that the tumor tissue contained the usual amount 
of antigenic material,  namely, masked or altered virus.  The conclusion would 
seem warranted that the latter had  increased  to  the  usual  extent  as  the  V2 
carcinoma grew in the  hyperimmune  hosts. 
COMMENT 
It is generally recognized now that viruses are  protected from the action of 
specific antiviral antibodies so long as they remain associated with living  sus- 
ceptible cells."  No exception to the rule has been discerned:  even the necro- 
It is of theoretical interest to speculate upon the mechanism whereby living cells 
protect viruses from the action of circulating antiviral antibodies.  Perhaps simplest 
is the assumption that viruses live within cells and have no contact with antibodies, 
these  being  presumably  kept  away by the  semipermeable  protoplasm.  But  it  is 
conceivable that specific  antiviral antibodies might still be ineffective even if they 
reached the vicinity of the virus.  This might be the case, for example,  if, in  the 
living cell,  there  were a  special association  between  the cell  constituents  and  that 
part of the virus to which the antibody would become attached in the absence of 
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tizing viruses are protected until they kill their cell hosts and thus expose them- 
selves to the action of the antibodies they have elicited (13).  The principle 
finds exquisite illustration in the case of the papilloma virus, which, inducing 
neoplastic proliferation, continues to exert its effects and to increase in amount 
in association with cells that are nourished  by blood which would promptly 
render the virus inactive in the lack of cell protection (14). 
The same state of affairs exists in the V2 carcinoma, and under conditions 
even more extreme; for the virus continues to increase even when the growth is 
propagated in hosts previously immunized against it, as the foregoing experi- 
ments have shown.  The outcome is notably different, however, in the case of 
certain of the extraneous viruses that sometimes ride along as passengers in 
transplanted cancers.  For, as already mentioned, virus III and vaccine virus-- 
the only ones tested thus far in this relation--are eliminated if the tumors they 
ride upon are propagated in hosts previously immunized against them (6, 7). 
It is conceivable that the passenger viruses disappear because not sufficiently 
protected, but this is not necessarily so.  Both of the aforementioned viruses 
can survive in tumors after the hosts become immune to them (16),--findings 
which show clearly that tumor cells are capable of protecting some passenger 
viruses, at least against ordinary amounts of antibody. 
The disabilities inherent in the characters and effects of passenger viruses will 
sufficiently account for their disappearance from tumors propagated in virus- 
immune hosts.  Many of them sooner or later kill the cells susceptible to them; 
and under ordinary circumstances they rely upon passage to new cells for sur- 
vival and increase.  None is a  neoplastic virus,  going  along  with  cells  that 
proliferate continually as result of its action.  Their disappearance from tumors 
propagated in virus-immune hosts could be explained by supposing that they 
infect relatively few of the tumor cells at any one time, that they seriously in- 
terfere with cellular proliferation, and that they maintain their association with 
the tumors chiefly by virtue of their ability to pass from dead or dying cells to 
living susceptible ones, instead of going along as the cells divide.  For under 
such circumstances the neutralizing antibody already present in the new host 
would inactivate any virus liberated from the infected cells and preclude the 
infection of susceptible ones, and the uninfected cells would sooner or later out- 
grow those hampered by the parasite. 
This does not mean that all passenger viruses would necessarily be eliminated 
by similar means.  Certain extrinsic viruses can adapt themselves notably well 
to tumor cells, as witness the persistence of fowl pest and lymphogranuloma 
viruses in tumors apparently unaffected by them (17).  But it is one thing to go 
along with a  tumor and another to be its cause or to modify its neoplastic 
character.  None of the passenger viruses thus far studied has either of these 
effects though some induce the formation of inclusion bodies in tumor cells and 
many cause cellular necrosis and thus deter tumor growth (4).  In sum, how- jom~  o.  r~DD  19 
ever, the passenger viruses are all mere riders.  The papilloma virus on the 
other hand is not only responsible for the causation and continued proliferation 
of tumors, but it has proved capable of rendering malignant many benign tar 
tumors of the rabbit and of hastening the growth and modifying the character 
of others, both malignant and benign, when brought into contact with them 
experimentally  (15).  In previous  papers  facts  have  been  presented  which 
attest to the continued neoplastic activities of the virus in partnership with the 
V2 carcinoma ceils (3, 15). 
SUMMARY 
The V2 carcinoma--a transplanted rabbit cancer derived originally from a 
virus-induced papilloma and  carrying in masked or altered form the  virus 
primarily responsible  for  it--was  propagated  in  five  successive  groups  of 
animals  all  previously hyperimmunized against  the  papilloma  virus.  The 
cancer grew as well in the hyperimmunized hosts as in normal animals im- 
planted during the same months; and serological tests, made when the tumor 
was  eventually returned  to ordinary hosts, proved  that the virus was still 
associated with the carcinoma cells: it had increased to the usual extent as the 
tumor grew in the hyperimmune animals. 
The continued increase of the neoplastic virus during propagation of the 
V2 carcinoma in hyperimmunized hosts contrasts sharply with the elimination 
of certain extraneous passenger viruses when the tumors they ride upon are 
grown in hosts previously immunized against them.  The facts as a  whole 
would seem to warrant a  distinction between the enduring partnership of a 
neoplastic virus and  carcinoma cells on the one hand and the casual associa- 
tion of passenger viruses with tumor cells on the other. 
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